Brainstorm Cell Therapeutics Inc. (BCLI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 0.2049 |
| Open | 0.2199 |
| Bid | 0.2200 x 900 |
| Ask | 0.2300 x 1000 |
| Day's Range | 0.2000 - 0.3000 |
| 52 Week Range | 0.1700 - 4.4800 |
| Volume | |
| Avg. Volume | 571,471 |
| Market Cap | 9.008M |
| Beta (5Y Monthly) | -0.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5900 |
| Earnings Date | Nov 13, 2023 - Nov 17, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.00 |
Simply Wall St.Brainstorm Cell Therapeutics Inc.'s (NASDAQ:BCLI) Path To Profitability
Brainstorm Cell Therapeutics Inc. ( NASDAQ:BCLI ) is possibly approaching a major achievement in its business, so we...
- Thomson Reuters StreetEvents
Q2 2023 Brainstorm Cell Therapeutics Inc Earnings Call
Q2 2023 Brainstorm Cell Therapeutics Inc Earnings Call
- Simply Wall St.
While institutions own 23% of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), retail investors are its largest shareholders with 59% ownership
Key Insights Brainstorm Cell Therapeutics' significant retail investors ownership suggests that the key decisions are...
© 2023 Yahoo. All rights reserved.
